The Effect of Whole-Body Cryotherapy at Different Temperatures on Proinflammatory Cytokines, Oxidative Stress Parameters, and Disease Activity in Patients with Ankylosing Spondylitis

Purpose Patients with ankylosing spondylitis (AS) have increased production of proinflammatory cytokines, increased oxidants, and decreased antioxidant capacity. The aim of this study was to determine the effect of whole-body cryotherapy (WBC) at −110°C and −60°C, on disease activity, selected proinflammatory cytokines, and oxidative stress in patients with AS. Methods Sixty-five patients with AS were recruited to one of three study procedures: WBC at −110°C, −60°C, or exercise therapy (non-WBC). The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondylitis Disease Activity Score (ASDAS-CRP), concentration of C-reactive protein (CRP), and the concentrations of interleukin 8 and 17 (IL-8, IL-17) were measured at the beginning of the study and at the end of the intervention. The concentration of thiobarbituric acid reactive substances (TBARS), as a lipid peroxidation result, and total antioxidant status, an antioxidant organism potential, were measured. Results All the studied groups showed significantly decreased posttherapy disease activity expressed as a function of the BASDAI, ASDAS-CRP, and the IL-8 concentration. We found that the TBARS concentration after therapy was significantly increased in the WBC at −110°C group. A comparison of the therapeutic effects between the treatment groups showed a significantly lower BASDAI after therapy in the WBC at −110°C group compared to the non-WBC group. Conclusion WBC at −110°C had a positive effect on lowering AS clinical activity as measured by the BASDAI.

[1]  D. Pyne,et al.  Whole-Body Cryotherapy: Potential to Enhance Athlete Preparation for Competition? , 2019, Front. Physiol..

[2]  L. Pazart,et al.  Local ice cryotherapy decreases synovial interleukin 6, interleukin 1β, vascular endothelial growth factor, prostaglandin-E2, and nuclear factor kappa B p65 in human knee arthritis: a controlled study , 2019, Arthritis Research & Therapy.

[3]  A. Sieroń,et al.  Decreased Oxidative Stress in Male Patients with Active Phase Ankylosing Spondylitis Who Underwent Whole-Body Cryotherapy in Closed Cryochamber , 2018, Oxidative medicine and cellular longevity.

[4]  A. Sieroń,et al.  Whole-Body Cryotherapy Decreases the Levels of Inflammatory, Oxidative Stress, and Atherosclerosis Plaque Markers in Male Patients with Active-Phase Ankylosing Spondylitis in the Absence of Classical Cardiovascular Risk Factors , 2018, Mediators of inflammation.

[5]  H. Kautiainen,et al.  The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis , 2017, Rheumatology International.

[6]  A. Sieroń,et al.  Effect of Whole-Body Cryotherapy on Antioxidant Systems in Experimental Rat Model , 2017, Oxidative medicine and cellular longevity.

[7]  F. Grappe,et al.  Whole- and partial-body cryostimulation/cryotherapy: Current technologies and practical applications. , 2016, Journal of thermal biology.

[8]  P. Miossec,et al.  IL-17 in Chronic Inflammation: From Discovery to Targeting. , 2016, Trends in molecular medicine.

[9]  D. Solmaz,et al.  Oxidative stress and related factors in patients with ankylosing spondylitis. , 2016, European journal of rheumatology.

[10]  P. Bowness,et al.  The interleukin (IL)‐23/IL‐17 axis in ankylosing spondylitis: new advances and potentials for treatment , 2016, Clinical and experimental immunology.

[11]  Yi Zhong,et al.  Assessment of ankylosing spondylitis by serum cytokine profile , 2016 .

[12]  W. Romanowski,et al.  Effects of Whole-Body Cryotherapy in Comparison with Other Physical Modalities Used with Kinesitherapy in Rheumatoid Arthritis , 2015, BioMed research international.

[13]  G. Tsokos,et al.  Update on the role of Interleukin 17 in rheumatologic autoimmune diseases. , 2015, Cytokine.

[14]  A. Sieroń,et al.  Can Whole-Body Cryotherapy with Subsequent Kinesiotherapy Procedures in Closed Type Cryogenic Chamber Improve BASDAI, BASFI, and Some Spine Mobility Parameters and Decrease Pain Intensity in Patients with Ankylosing Spondylitis? , 2015, BioMed research international.

[15]  B. Augustyńska,et al.  Physical Exercise Combined with Whole-Body Cryotherapy in Evaluating the Level of Lipid Peroxidation Products and Other Oxidant Stress Indicators in Kayakers , 2014, Oxidative medicine and cellular longevity.

[16]  P. Ghosh,et al.  Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis , 2014, Clinical Rheumatology.

[17]  L. Mourot,et al.  Cryotherapy in inflammatory rheumatic diseases: a systematic review , 2014, Expert review of clinical immunology.

[18]  Judith A. Smith Update on Ankylosing Spondylitis: Current Concepts in Pathogenesis , 2014, Current Allergy and Asthma Reports.

[19]  G. Banfi,et al.  Effects of 15 consecutive cryotherapy sessions on the clinical output of fibromyalgic patients , 2013, Clinical Rheumatology.

[20]  W. Romanowski,et al.  Effects of different local cryotherapies on systemic levels of TNF-α, IL-6, and clinical parameters in active rheumatoid arthritis , 2013, Rheumatology International.

[21]  W. Romanowski,et al.  A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis , 2013, Journal of Bone and Mineral Metabolism.

[22]  R. Pecoits-Filho,et al.  IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents , 2013, Rheumatology International.

[23]  R. Burgos-Vargas,et al.  In Vivo Peripheral Blood Proinflammatory T Cells in Patients with Ankylosing Spondylitis , 2012, The Journal of Rheumatology.

[24]  Basit Saleem Qazi,et al.  Recent Advances in Underlying Pathologies Provide Insight into Interleukin-8 Expression-Mediated Inflammation and Angiogenesis , 2011, International journal of inflammation.

[25]  A. Lubkowska,et al.  The effect of prolonged whole-body cryostimulation treatment with different amounts of sessions on chosen pro- and anti-inflammatory cytokines levels in healthy men , 2011, Scandinavian journal of clinical and laboratory investigation.

[26]  D. Ye,et al.  Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis , 2011, Clinical Rheumatology.

[27]  G. Banfi,et al.  Whole-Body Cryotherapy in Athletes , 2010, Sports medicine.

[28]  A. Sieroń,et al.  Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis. , 2010, Clinical biochemistry.

[29]  S. Akar,et al.  Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor , 2010, Modern rheumatology.

[30]  E. Miller,et al.  Effects of the whole-body cryotherapy on a total antioxidative status and activities of some antioxidative enzymes in blood of patients with multiple sclerosis-preliminary study. , 2010, The journal of medical investigation : JMI.

[31]  A. Wiczkowski,et al.  Influence of Cryogenic Temperatures on Inflammatory Markers in Patients with Ankylosing Spondylitis , 2010 .

[32]  D. Wendling IL-23 and IL-17 in ankylosing spondylitis , 2010, Rheumatology International.

[33]  A. Lubkowska,et al.  Do sessions of cryostimulation have influence on white blood cell count, level of IL6 and total oxidative and antioxidative status in healthy men? , 2010, European Journal of Applied Physiology.

[34]  C. B. Pickett,et al.  The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress* , 2009, Journal of Biological Chemistry.

[35]  M. Dougados,et al.  The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis , 2009, Annals of the rheumatic diseases.

[36]  P. Miossec IL-17 and Th17 cells in human inflammatory diseases. , 2009, Microbes and infection.

[37]  M. May,et al.  [Whole-body cryotherapy in patients with inflammatory rheumatic disease. A prospective study]. , 2009, Medizinische Klinik.

[38]  H. Ernst,et al.  Ganzkörperkryotherapie bei Patienten mit entzündlich-rheumatischen Erkrankungen , 2009, Medizinische Klinik.

[39]  Zhiming Lin,et al.  Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis , 2009, Rheumatology International.

[40]  P. Parren,et al.  IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis1 , 2008, The Journal of Immunology.

[41]  O. Altındag,et al.  Serum oxidative–antioxidative status in patients with ankylosing spondilitis , 2007, Rheumatology International.

[42]  H. Kautiainen,et al.  Effectiveness of different cryotherapies on pain and disease activity in active rheumatoid arthritis. A randomised single blinded controlled trial. , 2006, Clinical and experimental rheumatology.

[43]  A. Young,et al.  Intracellular monocyte and serum cytokine expression is modulated by exhausting exercise and cold exposure. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[44]  F. Marino,et al.  Thermoregulatory, metabolic and sympathoadrenal responses to repeated brief exposure to cold. , 1998, Scandinavian journal of clinical and laboratory investigation.

[45]  K. Madden,et al.  The role of the sympathetic nervous system in the modulation of immune responses. , 1998, Advances in pharmacology.

[46]  E. L. Persons,et al.  Ankylosing Spondylitis , 1955, GP.